US Patent Issued to Prelude Therapeutics on Sept. 16 for "Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)" (Pennsylvania, Delaware Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,414,953, issued on Sept. 16, was assigned to Prelude Therapeutics Inc. (Willmington, Del.).

"Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)" was invented by Ganfeng Cao (Chadds Ford, Pa.), Qun Li (Newark, Del.), Huaping Zhang (Newark, Del.) and Hongwu Yu (Newark, Del.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure is directed to pharmaceutically acceptable salts of the compound of Formula I (I). Pharmaceutical compositions comprising pharmaceutically acceptable salts of the compound of Formula I, as well as methods of their use and preparation, are also described."

The patent was filed on Sept. 18, 2020, under Appl...